"BlueRock Therapeutics’ Phase 1 trial testing DA01 ... has completed enrolling its first group of patients with advanced Parkinson’s disease.
Meanwhile, enrolment for the second and final high-dose cohort of the open-label trial (NTC04802733) is still ongoing at sites in the U.S. and Canada."
Someone from the forum wrote that we should focus on trials that are at least phase 3. I stopped posting these early phase 1 clinical trials.
I disagree. I think a better approach would be to mention the phase number in the title of the post, so those who only want to read about Phase 3 trials can skip posts about other phases.
I've edited the title of this post accordingly.
sure thing.
People post all kinds of things on this forum, including poorly done mouse studies and cell culture studies. My pet peeve is when the same newsy PR gets repeat posted five or six times. Trying to control what people post is hopeless. A phase 1 human study is more relevant than most.
Good point. At least human studies are more relevant.
Another point to make is that you can only volunteer for trials that you know about. I would volunteer for this BlueRock Phase 1 trial if I was eligible.
advanced Parkinson’s disease.
I like it. Could actually benefit some of us already in the game, if it ends up working.
Parkinson's Disease Clinical trial for First in Humans use of FGF-1 to treat Parkinson's Disease started by Zhittya Genesis Medicine.A (minor) update by Inhibikase Therapeutics on their Phase 2 trial of Risvodetinib (IkT-148009) for Parkinson's Disease.Monkeys Aren't Human and Animal \"Models\" of Parkinson's Disease Aren't Actually Parkinson's Disease, BUT This Stem Cell Trial Offers Hope!
Potential disease-modifying therapy enters Phase 2First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's 
